166 related articles for article (PubMed ID: 29039348)
21. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.
Sieber J; Daridon C; Fleischer SJ; Fleischer V; Hiepe F; Alexander T; Heine G; Burmester GR; Fillatreau S; Dörner T
Arthritis Res Ther; 2014 Nov; 16(6):477. PubMed ID: 25385499
[TBL] [Abstract][Full Text] [Related]
22. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
24. Exhaled cytokines in systemic lupus erythematosus with lung involvement.
Nielepkowicz-Goździńska A; Fendler W; Robak E; Kulczycka-Siennicka L; Górski P; Pietras T; Brzeziańska E; Antczak A
Pol Arch Med Wewn; 2013; 123(4):141-8. PubMed ID: 23467253
[TBL] [Abstract][Full Text] [Related]
25. [Expression of regulatory B cells in peripheral blood of patients with systemic lupus erythematosus].
Cai X; Li X; Lin X; Tang C; Ye J; Li W; He Z; Li F; Xu Y
Zhonghua Yi Xue Za Zhi; 2015 May; 95(17):1310-3. PubMed ID: 26081660
[TBL] [Abstract][Full Text] [Related]
26. [Abnormality and significance of interleukin-9 and CD4(+)interleukin-9(+) T-cells in peripheral blood of patients with systemic lupus erythematosus].
Ouyang H; Shi YB; Su N; Li LY
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):99-103. PubMed ID: 23648344
[TBL] [Abstract][Full Text] [Related]
27. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
[TBL] [Abstract][Full Text] [Related]
28. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
Liu X; Wang C; Ye Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
[TBL] [Abstract][Full Text] [Related]
29. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus.
Badot V; Luijten RK; van Roon JA; Depresseux G; Aydin S; Van den Eynde BJ; Houssiau FA; Lauwerys BR
Ann Rheum Dis; 2013 Mar; 72(3):453-6. PubMed ID: 23264357
[TBL] [Abstract][Full Text] [Related]
30. IVIg attenuates TLR-9 activation in B cells from SLE patients.
Kessel A; Peri R; Haj T; Snir A; Slobodin G; Sabo E; Rosner I; Shoenfeld Y; Toubi E
J Clin Immunol; 2011 Feb; 31(1):30-8. PubMed ID: 20922561
[TBL] [Abstract][Full Text] [Related]
31. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes.
Liu TF; Jones BM
Cytokine; 1998 Feb; 10(2):140-7. PubMed ID: 9512904
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus.
Daza L; Lavalle C; Duarte C; Huerta R; Moreno J
Lupus; 2003; 12(2):107-11. PubMed ID: 12630754
[TBL] [Abstract][Full Text] [Related]
33. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls.
Jacobi AM; Rohde W; Volk HD; Dörner T; Burmester GR; Hiepe F
Ann Rheum Dis; 2001 Mar; 60(3):242-7. PubMed ID: 11171686
[TBL] [Abstract][Full Text] [Related]
34. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA
Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
[TBL] [Abstract][Full Text] [Related]
35. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
[TBL] [Abstract][Full Text] [Related]
36. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
37. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of PBMC Distribution and TLR9 Expression in Patients with Systemic Lupus Erythematosus.
Mortezagholi S; Babaloo Z; Rahimzadeh P; Ghaedi M; Namdari H; Assar S; Azimi Mohamadabadi M; Salehi E
Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):229-36. PubMed ID: 27424138
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients.
Huang X; Hua J; Shen N; Chen S
Mod Rheumatol; 2007; 17(3):220-3. PubMed ID: 17564777
[TBL] [Abstract][Full Text] [Related]
40. The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens.
Rodriguez E; Guevara J; Paez A; Zapata E; Collados MT; Fortoul TI; Lopez-Marure R; Masso F; Montaño LF
Lupus; 2008 Dec; 17(12):1086-95. PubMed ID: 19029276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
